Tandem Diabetes Care
TNDM
273 hedge funds and large institutions have $2.93B invested in Tandem Diabetes Care in 2019 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 94 increasing their positions, 87 reducing their positions, and 33 closing their positions.
39% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 33
5% more funds holding
Funds holding: 261 → 273 (+12)
3.78% more ownership
Funds ownership: 80.97% → 84.75% (+3.8%)
8% more repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 87
7% more call options, than puts
Call options by funds: $59.2M | Put options by funds: $55.1M
3% less capital invested
Capital invested by funds: $3.03B → $2.93B (-$102M)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$65.3M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$35.1M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$29.5M |
| 4 |
Renaissance Technologies
New York
|
+$25.3M |
| 5 |
SIMG
Stephens Investment Management Group
Houston,
Texas
|
+$23.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$49.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$49M |
| 3 |
Millennium Management
New York
|
-$28.2M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$22.9M |
| 5 |
FAM
Fred Alger Management
New York
|
-$13.7M |
TNDM Hedge Fund Activity: Q3 2019 in Review
273 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q3 2019, worth a combined $2.93B — down 3.4% from $3.03B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new TNDM positions and 33 closed out — a net gain of 13 holders — while 94 added to existing stakes and 87 trimmed.
The largest buyer was Consonance Capital Management, opening a new position worth an estimated $65.3M. The largest seller was Lord, Abbett & Co, cutting an estimated $49.1M.
- 273 institutional investors held Tandem Diabetes Care (TNDM) as of Q3 2019, up from 261 in Q2 2019.
- Funds reported $2.93B of Tandem Diabetes Care stock for Q3 2019, down 3.4% quarter-over-quarter.
- 46 funds opened new Tandem Diabetes Care positions in Q3 2019 and 33 closed out, a net change of +13 holders.
- The largest Tandem Diabetes Care buyer in Q3 2019 was Consonance Capital Management, an estimated $65.3M added.
- The largest Tandem Diabetes Care seller in Q3 2019 was Lord, Abbett & Co, an estimated $49.1M sold.
Based on aggregated 13F filings for Q3 2019.